Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.565
+0.065 (4.33%)
Aug 13, 2025, 1:55 PM - Market open
Neumora Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2020 |
Cash & Equivalents | 124.52 | 142.15 | 374.04 | 240.94 | 409.25 | 191.98 | Upgrade |
Short-Term Investments | 93.07 | 165.43 | 79.94 | 130.94 | - | - | Upgrade |
Cash & Short-Term Investments | 217.59 | 307.58 | 453.98 | 371.88 | 409.25 | 191.98 | Upgrade |
Cash Growth | -41.45% | -32.25% | 22.08% | -9.13% | 113.17% | - | Upgrade |
Other Receivables | - | - | - | 0.92 | 0.2 | 0.15 | Upgrade |
Receivables | - | - | - | 0.92 | 0.2 | 0.15 | Upgrade |
Prepaid Expenses | 5.32 | 5.26 | 18 | 1.62 | 1.2 | 0.78 | Upgrade |
Restricted Cash | - | 1.21 | - | 0.05 | 0.13 | 0.13 | Upgrade |
Other Current Assets | - | - | 6.3 | 13.48 | 4.84 | 0.81 | Upgrade |
Total Current Assets | 222.91 | 314.06 | 478.28 | 387.96 | 415.6 | 193.84 | Upgrade |
Property, Plant & Equipment | 0.62 | 2.92 | 6.86 | 10.64 | 4.04 | 3.92 | Upgrade |
Long-Term Investments | - | - | 9.85 | 23.51 | - | - | Upgrade |
Long-Term Deferred Charges | - | - | - | 2.9 | 1.83 | - | Upgrade |
Other Long-Term Assets | 0.3 | - | 1.21 | 1.23 | 7.82 | 0.18 | Upgrade |
Total Assets | 223.83 | 316.97 | 496.2 | 426.23 | 429.3 | 197.95 | Upgrade |
Accounts Payable | 0.64 | 3.31 | 0.34 | 7.15 | 1.64 | 2.4 | Upgrade |
Accrued Expenses | 20.25 | 24.59 | 21.26 | 11.54 | 19.1 | 5.6 | Upgrade |
Current Portion of Leases | 0.17 | 1.85 | 3.38 | 3.37 | 1.06 | 0.76 | Upgrade |
Other Current Liabilities | 0.09 | 0.13 | 0.14 | 1.64 | 1.49 | 0.61 | Upgrade |
Total Current Liabilities | 21.16 | 29.89 | 25.11 | 23.7 | 23.28 | 9.37 | Upgrade |
Long-Term Leases | 0.34 | - | 1.85 | 5.07 | 1 | 1.28 | Upgrade |
Other Long-Term Liabilities | - | 0.02 | 0.16 | 0.63 | 0.39 | - | Upgrade |
Total Liabilities | 40.95 | 29.91 | 27.12 | 29.4 | 24.66 | 10.65 | Upgrade |
Common Stock | 0.02 | 0.02 | 0.02 | 0 | 0.01 | 0.01 | Upgrade |
Additional Paid-In Capital | 1,251 | 1,234 | 1,173 | 21.43 | 11.37 | 4.9 | Upgrade |
Retained Earnings | -1,068 | -947.22 | -703.43 | -467.51 | -336.61 | -99.29 | Upgrade |
Comprehensive Income & Other | -0.02 | 0.06 | -0.08 | -0.77 | - | - | Upgrade |
Total Common Equity | 182.88 | 287.06 | 469.08 | -446.85 | -325.22 | -94.38 | Upgrade |
Shareholders' Equity | 182.88 | 287.06 | 469.08 | 396.84 | 404.64 | 187.3 | Upgrade |
Total Liabilities & Equity | 223.83 | 316.97 | 496.2 | 426.23 | 429.3 | 197.95 | Upgrade |
Total Debt | 19.96 | 1.85 | 5.23 | 8.44 | 2.05 | 2.05 | Upgrade |
Net Cash (Debt) | 197.63 | 305.73 | 458.6 | 386.95 | 407.2 | 189.93 | Upgrade |
Net Cash Growth | -46.30% | -33.34% | 18.52% | -4.97% | 114.39% | - | Upgrade |
Net Cash Per Share | 1.23 | 1.92 | 7.05 | 14.22 | 18.60 | 14.61 | Upgrade |
Filing Date Shares Outstanding | 161.95 | 161.98 | 158.89 | 32.61 | 31.98 | 30.61 | Upgrade |
Total Common Shares Outstanding | 161.95 | 161.71 | 158.83 | 32.61 | 31.98 | 30.61 | Upgrade |
Working Capital | 201.75 | 284.17 | 453.17 | 364.26 | 392.33 | 184.47 | Upgrade |
Book Value Per Share | 1.13 | 1.78 | 2.95 | -13.70 | -10.17 | -3.08 | Upgrade |
Tangible Book Value | 182.88 | 287.06 | 469.08 | -446.85 | -325.22 | -94.38 | Upgrade |
Tangible Book Value Per Share | 1.13 | 1.78 | 2.95 | -13.70 | -10.17 | -3.08 | Upgrade |
Machinery | - | 3.19 | 3.18 | 2.94 | 2.3 | 1.83 | Upgrade |
Construction In Progress | - | - | 0.04 | 0.51 | 0.22 | - | Upgrade |
Leasehold Improvements | - | - | - | 0.02 | 0.26 | 0.21 | Upgrade |
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.